HMGB1 and cancer: Hatada et al. reported the elevation of plasma HMGB1 levels in patients with infectious diseases, malignancies, and traumas and suggested that HMGB1 is a potentially suitable prognostic marker of organ failure or disseminated intravascular coagulation [69].